Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CURA.TO) Revenue
Annual & quarterly revenue history · segment & region breakdown
CURA.TO · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCuraleaf Holdings, Inc. trailing twelve-month (TTM) revenue is $1.29B, a decrease of 3.91% year-over-year from $1.29B in FY2025.
Revenue trend
2025 – 2014 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.29B | -$0.05B | -3.91% |
| 2024-12-31 | $1.34B | -$0.00B | -0.28% |
| 2023-12-31 | $1.35B | +$0.01B | +0.77% |
| 2022-12-31 | $1.34B | +$0.13B | +10.47% |
| 2021-12-31 | $1.21B | +$0.58B | +93.04% |
| 2020-12-31 | $0.63B | +$0.41B | +183.52% |
| 2019-12-31 | $0.22B | +$0.14B | +186.82% |
| 2018-12-31 | $0.08B | +$0.06B | +298.99% |
| 2017-12-31 | $0.02B | +$0.02B | +420.85% |
| 2016-12-31 | $0.00B | +$0.00B | — |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare CURA.TO revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Curaleaf Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Curaleaf Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Curaleaf Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CURA.TO revenue · 4 questionsCURA.TO's trailing twelve-month (TTM) revenue is $1.29B. That is a decrease of 3.91% year-over-year from $1.29B in FY2025.
▸ Source: FMP · Curaleaf Holdings, Inc. SEC filings · GAAP · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026